➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Boehringer Ingelheim
Dow
AstraZeneca
Medtronic

Last Updated: May 31, 2020

DrugPatentWatch Database Preview

CARBIDOPA AND LEVODOPA Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Carbidopa And Levodopa, and when can generic versions of Carbidopa And Levodopa launch?

Carbidopa And Levodopa is a drug marketed by Accord Hlthcare, Alembic Pharms Ltd, Apotex, Impax Labs, Kv Pharm, Mylan, Sun Pharm Inds, Sun Pharm, Actavis Elizabeth, Ani Pharms Inc, Apotex Inc, Mayne Pharma, SCS, and Watson Labs. and is included in twenty-two NDAs.

The generic ingredient in CARBIDOPA AND LEVODOPA is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.

Drug patent expirations by year for CARBIDOPA AND LEVODOPA
Drug Prices for CARBIDOPA AND LEVODOPA

See drug prices for CARBIDOPA AND LEVODOPA

Recent Clinical Trials for CARBIDOPA AND LEVODOPA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Vanderbilt University Medical CenterPhase 1
United States Department of DefensePhase 1
Second Affiliated Hospital of Wenzhou Medical UniversityPhase 2

See all CARBIDOPA AND LEVODOPA clinical trials

Pharmacology for CARBIDOPA AND LEVODOPA
Synonyms for CARBIDOPA AND LEVODOPA
3-(3,4-Dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid--3-hydroxytyrosine (1/1)
500019-90-9
57308-51-7
Carbidopa / Levodopa
Carbidopa Levodopa
Carbidopa mixture with Levodopa
Carbidopa-L-dopa mixt
Carbidopa-L-dopa mixt.
Carbidopa-levodopa (1:10)
Carbidopa-levodopa ER
Carbidopa-levodopa extended release
Carbidopa-levodopa mixt
Carbidopa-levodopa mixt.
carbidopa, levodopa drug combination
Carbidopa/levodopa
CHF 1512
Co-careldopa
CR-3
CR-5
DM-1992
Dopabain
DTXSID00964491
Duodopa
Duopa
IPX 066
IPX066
Isicom
IVTMXOXVAHXCHI-YXLMWLKOSA-N
L-Tyrosine, 3-hydroxy-, mixt. with (S)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid
L-Tyrosine, 3-hydroxy-, mixt. with (S)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid (10:1)
Levodopa / carbidopa
levodopa carbidopa
Levodopa-carbidopa (10:1)
Levodopa/Carbidopa Solution
LS-158296
Nacom
Nakom
ND 0612
ND0612
Q5037862
Rytary
SCHEMBL2049245
Sinemet CR
Sinemet CR4

US Patents and Regulatory Information for CARBIDOPA AND LEVODOPA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 078536-001 Oct 28, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
Mayne Pharma CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 073618-001 Aug 28, 1992 AB RX No No   Start Trial   Start Trial   Start Trial
Watson Labs CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 073382-001 Sep 28, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 073587-003 Jun 29, 1995 DISCN No No   Start Trial   Start Trial   Start Trial
Mayne Pharma CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 073589-001 Aug 28, 1992 AB RX No No   Start Trial   Start Trial   Start Trial
Apotex Inc CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 077120-001 Jun 2, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
Accord Hlthcare CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 202323-001 Feb 8, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Boehringer Ingelheim
Dow
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.